KKR Health Care Strategic Growth Fund II SCSp, managed by KKR & Co. Inc. (NYSE:KKR) agreed to acquire an unknown majority stake in Clinisupplies Limited from Healthium Medtech Limited on December 6, 2022. Management team of Clinisupplies will continue to hold a minority position in Clinisupplies Limited. Claus Bjerre KKR Senior Advisor and former Chief Executive Officer of Atos Medical AB and former President North America, of Coloplast, will serve as Chairman of Clinisupplies? Board of Directors. Douglas Le Fort KKR?s broader advisor and expert network, industry veteran will also join the Board of Directors of Clinisupplies. Houlihan Lokey Capital, Inc. acted as financial advisor, Nicholas Tomlinson and Wim De Vlieger of Gibson, Dunn & Crutcher LLP acted as legal advisor to KKR & Co. Inc. The Boston Consulting Group, Inc. acted as commercial Due diligence provider and PricewaterhouseCoopers LLP acted as financial & tax advisor to KKR & Co. Inc. (NYSE:KKR). Darshika Kothari, Kunal Kumbhat of AZB & Partners acted as legal advisor to KKR & Co. Inc. (NYSE:KKR). RBC Capital Markets Inc. acted as exclusive financial advisor and Kirkland & Ellis LLP as legal advisor to Apax-backed Healthium Medtech. Karen Guch of Baker McKenzie acted as legal advisor to KKR.

KKR Health Care Strategic Growth Fund II SCSp, managed by KKR & Co. Inc. (NYSE:KKR) completed the acquisition of an unknown majority stake in Clinisupplies Limited from Healthium Medtech Limited on January 18, 2023.